Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy

Rituximab (RTX), an anti-CD20 monoclonal antibody, has shown to be an effective induction treatment for small-vessel vasculitides associated with antineutrophil cytoplasm antibodies (AAV) in both newly diagnosed and relapsing patients. However, the role of RTX in the management of the most severe ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Roccatello, Dario, Sciascia, Savino, Murgia, Stefano, Quattrocchio, Giacomo, Ferro, Michela, De Simone, Emanuele, Naretto, Carla, Barreca, Antonella, Sammartino, Andrea, Rossi, Daniela, Fenoglio, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988143/
https://www.ncbi.nlm.nih.gov/pubmed/35401565
http://dx.doi.org/10.3389/fimmu.2022.777134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988143/
https://www.ncbi.nlm.nih.gov/pubmed/35401565
http://dx.doi.org/10.3389/fimmu.2022.777134

Ejemplares similares